Skip to main content

The context you need, when you need it

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our own.

We rely on readers like you to fund our journalism. Will you support our work and become a Vox Member today?

Join now

Nasty Gal is expected to file for bankruptcy

Founder Sophia Amoruso will also resign as executive chairwoman of the online clothing retailer.

Girlboss x Prudential Brunch
Girlboss x Prudential Brunch
Nasty Gal founder Sophia Amoruso
Randy Shropshire/Getty Images for Girlboss, Inc.

According to sources close to the situation, Nasty Gal is preparing to file for Chapter 11 bankruptcy protection, allowing it to reorganize its business.

In addition, said sources, founder Sophia Amoruso is resigning as executive chairwoman. The hip online clothing seller, aimed at fashion-forward young women for whom Amoruso had become a heroine, is telling its employees today and will be filing publicly soon. Sources added that director Danny Rimer is also expected to step down from the board.

Amoruso’s departure caps what has been a tumultuous two years at the onetime e-commerce darling. Nasty Gal has conducted layoffs both this year and last, gone through a CEO change, and been the target of lawsuits by several former employees. Nasty Gal has also explored a sale of the company, said sources.

Amoruso founded Nasty Gal in 2006, when she was only 22, as a vintage shop on eBay. Over the years, she grew the Los Angeles-based company into an online business with around $100 million in sales. It was fueled by a passionate customer base among millennial women and a personal fan base, thanks in part to her New York Times bestseller “#Girlboss.” The company also operates two stores in the Los Angeles area.

Nasty Gal has been largely funded by Index Ventures, which put $49 million into the company in 2012. But in February of 2015, well-known retail exec Ron Johnson added $16 million to the mix. Sources said that he and private equity partners have been trying to add more funding in exchange for what could be a cram-down of existing investors.

Obviously, that did not work, in what one person with knowledge of the situation called a “too-little-too-late scenario.”

More to come as this story develops. Nasty Gal could do anything from shedding its stores and warehouses to cutting back on staff, but that is still undetermined, said sources.

Recode has contacted Amoruso, Johnson and Rimer for comment.

(And it goes without saying that while it’s a bad day for Nasty Gal, it is also one for Nasty Women all over.)

This article originally appeared on Recode.net.

More in Technology

Podcasts
Are humanoid robots all hype?Are humanoid robots all hype?
Podcast
Podcasts

AI is making them better — but they’re not going to be doing your chores anytime soon.

By Avishay Artsy and Sean Rameswaram
Future Perfect
The old tech that could help stop the next airborne pandemicThe old tech that could help stop the next airborne pandemic
Future Perfect

Glycol vapors, explained.

By Shayna Korol
Future Perfect
Elon Musk could lose his case against OpenAI — and still get what he wantsElon Musk could lose his case against OpenAI — and still get what he wants
Future Perfect

It’s not about who wins. It’s about the dirty laundry you air along the way.

By Sara Herschander
Life
Why banning kids from AI isn’t the answerWhy banning kids from AI isn’t the answer
Life

What kids really need in the age of artificial intelligence.

By Anna North
Culture
Anthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque messAnthropic owes authors $1.5B for pirating work — but the claims process is a Kafkaesque mess
Culture

“Your AI monster ate all our work. Now you’re trying to pay us off with this piece of garbage that doesn’t work.”

By Constance Grady
Future Perfect
Some deaf children are hearing again because of a new gene therapySome deaf children are hearing again because of a new gene therapy
Future Perfect

A medical field that almost died is quietly fixing one disease at a time.

By Bryan Walsh